These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1684634)

  • 41. Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.
    Fernandes A; de Oliveira EF; de Rezende IC; Ponzoni S
    Brain Res; 2010 Mar; 1317():277-85. PubMed ID: 20045397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
    Moukhles H; Nieoullon A; Daszuta A
    Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
    Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
    Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of a unilateral stereotaxic injection of Tinuvin 123 into the substantia nigra on the nigrostriatal dopaminergic pathway in the rat.
    Jackson-Lewis V; Liberatore G
    Brain Res; 2000 Jun; 866(1-2):197-210. PubMed ID: 10825495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
    Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
    J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides.
    Agnati LF; Fuxe K; Zini I; Davalli P; Corti A; Calza L; Toffano G; Zoli M; Piccinini G; Goldstein M
    Acta Physiol Scand; 1985 Aug; 124(4):499-506. PubMed ID: 2864781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
    Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
    Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra.
    Cumming P; Kamo H; McGeer EG; McGeer PL
    Neuropharmacology; 1987 Dec; 26(12):1795-7. PubMed ID: 2893988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
    Zhou FC; Bledsoe S; Murphy J
    Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-tyrosine hydroxylase activity in the rat brain after chronic oral administration of manganese chloride.
    Bonilla E
    Neurobehav Toxicol; 1980; 2(1):37-41. PubMed ID: 6108526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
    Nishi K; Kondo T; Narabayashi H
    Brain Res; 1989 Jun; 489(1):157-62. PubMed ID: 2568151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.
    Sengstock GJ; Olanow CW; Dunn AJ; Barone S; Arendash GW
    Exp Neurol; 1994 Nov; 130(1):82-94. PubMed ID: 7529713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons.
    Yong VW; Perry TL; Godolphin WJ; Jones KA; Clavier RM; Ito M; Foulks JG
    Neurotoxicology; 1986; 7(1):19-24. PubMed ID: 2872639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.